Background Bloodstream infections (BSIs) produced by antibiotic-resistant bacteria (ARB)
cause a substantial disease burden worldwide. However, most estimates come from high …

Background Hospital-associated infections (HAIs) are an important cause of morbidity and
mortality around the world. Many HAIs are caused by drug-resistant bacterial pathogens, but …

Background. It is unknown whether rising incidence rates of nosocomial bloodstream
infections (BSIs) caused by antibiotic-resistant bacteria (ARB) replace antibiotic-susceptible …

Objectives To assess the association between country income status and national
prevalence of invasive infections caused by the top-ranked bacteria on the WHO priority list …

Antibiotic resistance (ABR) threatens the effectiveness of infectious disease treatments and
contributes to increasing global morbidity and mortality. In this study, we systematically …

Summary Background The Global Point Prevalence Survey (Global-PPS) established an
international network of hospitals to measure antimicrobial prescribing and resistance …

Introduction Despite evidence of the high prevalence of antibiotic resistant infections in
developing countries, studies on the clinical and economic impact of antibiotic resistance …

Introduction Antibiotic resistance (ABR) has substantial global public health concerns. This
systematic review aimed to synthesise recent evidence estimating the economic burden of …

Community-onset bloodstream infections (CO-BSI) are major causes of severe febrile illness
and death worldwide. In light of new data and the growing problem of antimicrobial …

Background Bloodstream infections (BSI) are serious and life-threatening, associated with
high mortality and morbidity. In resource-limited settings, there is a paucity of data on …